Open Orphan launches Covid antibody testing service

Contract research organisation Open Orphan announced the launch of the ‘hVIVO Covid Clear Test’ on Thursday, its coronavirus antibody testing service, following the completion of installation, testing and training.

The AIM-traded firm said the antibody tests, which use the ‘Quotient MosaiQ’ system and ‘MosaiQ Covid-19 Antibody Microarray’, offered “best-in-class” Covid-19 antibody testing performance, and would require a full blood draw.

It said the hVIVO Covid Clear Test would be offered to large employer groups and channel partners including GP networks, nursing services, health clinics and private hospitals.

Samples would be tested in the Company's London laboratory, with results returned within 48 hours.

“hVIVO is a world class company with best in class scientists and facilities,” said executive chairman Cathal Friel.

“We are very excited to be offering this service and I am confident our work will help large companies and clinics in the UK test their staff and patients to ensure the safety of all employees.”

At 1221 BST, shares in Open Orphan were down 2.28% at 14.12p.